Relay Therapeutics
RLAY
#5432
Rank
ยฃ0.99 B
Marketcap
ยฃ5.72
Share price
-0.65%
Change (1 day)
55.26%
Change (1 year)

Revenue for Relay Therapeutics (RLAY)

Revenue in 2025 (TTM): ยฃ6.43 Million

According to Relay Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ6.26 Million. In 2024 the company made a revenue of ยฃ7.97 Million a decrease over the revenue in the year 2023 that were of ยฃ20.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Relay Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ6.43 M-19.29%
2024 ยฃ7.97 M-60.23%
2023 ยฃ20.05 M1656.6%
2022 ยฃ1.14 M-49.13%
2021 ยฃ2.24 M-96.3%
2020 ยฃ60.63 M
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA